Iksuda Therapeutics

Q: What is Iksuda Therapeutics's official website?

Iksuda Therapeutics's official website is www.iksuda.com

Q: What is Iksuda Therapeutics's Revenue?

Iksuda Therapeutics's revenue is <$5 Million

Q: What is Iksuda Therapeutics's SIC code?

Iksuda Therapeutics's SIC: 87,873

Q: What is Iksuda Therapeutics's NAICS code?

Iksuda Therapeutics's NAICS: 54,541

Q: How many employees does Iksuda Therapeutics have?

Iksuda Therapeutics has 11-50 employees

Q: What industry does Iksuda Therapeutics belong to?

Iksuda Therapeutics is in the industry of: Business Services , Research & Development

Q: What is Iksuda Therapeutics competition?

Iksuda Therapeutics top competitors include: ImmunoGenes , NBE - Therapeutics , CellMosaic , PolyTherics

Q: What technology does Iksuda Therapeutics use?

Some of the popular technologies that Iksuda Therapeutics uses are: Cloudflare Website Optimization, Cloudflare CDN, Microsoft 365, Google Tag Manager

Q: How do I contact Iksuda Therapeutics?

Iksuda Therapeutics contact info: Phone number: +44 1916031680 Website: www.iksuda.com

Q: What does Iksuda Therapeutics do?

Founded in 2007, headquartered in Newcastle upon Tyne, UK, About Iksuda Therapeutics is a biotechnology company focussed on the development of next generation Antibody Drug Conjugates (ADCs) designed to combat difficult-to-treat tumours, including those that are resistant or refractory to current treatment regimens. Iksuda's pipeline of stable and... superior ADCs is centered on its highly stable PermaLink® conjugation platform in combination with a portfolio of highly potent cytotoxic payloads designed to enhance antitumor activity and improve the lives of cancer patients. Read More

Business Services · United Kingdom · 11-50 Employees

View Company Info for Free

Overview

Headquarters

Helix Draymans Newcastle Way, Newcastle ...

Phone Number

+44 1916031680

Website

www.iksuda.com

Revenue

<$5 Million

Industry

Business Services

Research & Development

About Iksuda Therapeutics

Founded in 2007, headquartered in Newcastle upon Tyne, UK, About Iksuda Therapeutics is a biotechnology company focussed on the development of next generation Antibody Drug Conjugates (ADCs) designed to combat difficult-to-treat tumours, including those that are resistant or refractory to current treatment regimens. Iksuda's pipeline of stable and superior ADCs is centered on its highly stable PermaLink® conjugation platform in combination with a portfolio of highly potent cytotoxic payloads designed to enhance antitumor activity and improve the lives of cancer patients.Explore more

Is this data correct?

View contact profiles from Iksuda Therapeutics

SIC Code 87,873NAICS Code 54,541Show more

Iksuda Therapeutics Org Chart

Phone

Jutta Deckert

Vice President, Research & Development

Phone

Get the full picture

Tam Jackson

Senior CTM

Phone

Get the full picture

Compare Similar Companies to Iksuda Therapeutics

Compare insights from companies similar to Iksuda Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Iksuda Therapeutics

<$5M

11-50

Private

$47M

2007

Jutta DeckertVice President, Research & Development

NBE - Therapeutics

$6.9M

11-50

Private

$45.6M

2012

N/A

Bolt Biotherapeutics

$6.5M

11-50

Public

$340.5M

2015

Justin KenkelDirector, Tumor Immunology and In Vivo Pharmacology

Synaffix

$6.2M

11-50

Private

2010

N/A

ImmunoGenes

<$5M

11-50

Private

2008

Istvan KuruczManaging Director

PolyTherics

<$5M

11-50

Private

2002

N/A

CellMosaic

<$5M

1-10

Private

<$5M

2008

Subhakar DeyChief Technology Officer

View Email Formats for Iksuda Therapeutics

Iksuda Therapeutics Tech Stack

A closer look at the technologies used by Iksuda Therapeutics

Cloudflare Website Optimization

See more technologies

Top Business Services Companies

Frequently Asked Questions Regarding Iksuda Therapeutics

What is Iksuda Therapeutics's official website?

Iksuda Therapeutics's official website is www.iksuda.com

What is Iksuda Therapeutics's Revenue?

Iksuda Therapeutics's revenue is <$5 Million

What is Iksuda Therapeutics's SIC code?

Iksuda Therapeutics's SIC: 87,873

What is Iksuda Therapeutics's NAICS code?

Iksuda Therapeutics's NAICS: 54,541

How many employees does Iksuda Therapeutics have?

Iksuda Therapeutics has 11-50 employees

What industry does Iksuda Therapeutics belong to?

Iksuda Therapeutics is in the industry of: Business Services, Research & Development

What is Iksuda Therapeutics competition?

Iksuda Therapeutics top competitors include: ImmunoGenes, NBE - Therapeutics, CellMosaic, PolyTherics

What technology does Iksuda Therapeutics use?

Some of the popular technologies that Iksuda Therapeutics uses are: Cloudflare Website Optimization, Cloudflare CDN, Microsoft 365, Google Tag Manager

How do I contact Iksuda Therapeutics?

Iksuda Therapeutics contact info: Phone number: +44 1916031680 Website: www.iksuda.com

What does Iksuda Therapeutics do?

What are Iksuda Therapeutics social media links?

Iksuda Therapeutics Linkedin page Iksuda Therapeutics Twitter page

Who invested in Iksuda Therapeutics?

Iksuda Therapeutics has 3 investors including Celltrion, Mirae Asset Capital and Premier Partners.

Is Iksuda Therapeutics a public company?

Iksuda Therapeutics is private company therefore does not currently have an official ticker symbol

See more information about Iksuda Therapeutics

Sell Smarter. Win Faster.

Level up your game to ZoomInfo Copilot, intuitive AI that turns your data and high-quality ZoomInfo data into an unfair advantage for your go-to-market teams.